Xevant
PrivateLast Round
Series A
Feb 8, 2024
Total Funding Raised
$17.22M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Xevant is a healthcare technology company that provides a real-time, AI-powered analytics platform for organizations managing pharmacy benefits.
Sector
Healthcare & Life Sciences
Verticals
Healthcare Analytics, Vertical SaaS, Business Intelligence, Workflow Automation
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Xevant Comparables
Compare Xevant with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Scripta Insights | 79% | |
| Truveris | 76% | |
| McKesson | 71% | |
Xevant Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 8, 2024 | ||||
| Growth Equity | Mar 14, 2023 | ||||
| Series A | Dec 29, 2021 | ||||
| VC Round | Jan 6, 2021 |
Key People
Founding team and executive leadership
Xevant Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Decathlon Capital Partners | Series A |
| Tech Council Ventures | Series A, VC Round |
| Boston Millennia Partners | VC Round |
| Martinson Ventures | Series A, VC Round |
| Boston Millennia Partners | Series A, VC Round |
| HCAP Partners | Series A, Growth Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 29, 2026
Named a 2025 Modern Healthcare Best in Business company.
- Jun 11, 2025
Launched VerX, a new platform for pharmacy benefit optimization.
Xevant Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Xevant's valuation, stock price, and market status.